JP2023520409A5 - - Google Patents
Info
- Publication number
- JP2023520409A5 JP2023520409A5 JP2022559600A JP2022559600A JP2023520409A5 JP 2023520409 A5 JP2023520409 A5 JP 2023520409A5 JP 2022559600 A JP2022559600 A JP 2022559600A JP 2022559600 A JP2022559600 A JP 2022559600A JP 2023520409 A5 JP2023520409 A5 JP 2023520409A5
- Authority
- JP
- Japan
- Prior art keywords
- scfv
- sequence
- seq
- cell
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026050913A JP2026108769A (ja) | 2020-03-31 | 2026-03-25 | キメラ抗原受容体ターゲティングｃｄ３３ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003196P | 2020-03-31 | 2020-03-31 | |
| US63/003,196 | 2020-03-31 | ||
| PCT/US2021/025255 WO2021202799A2 (en) | 2020-03-31 | 2021-03-31 | Chimeric antigen receptors targeting cd33 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026050913A Division JP2026108769A (ja) | 2020-03-31 | 2026-03-25 | キメラ抗原受容体ターゲティングｃｄ３３ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520409A JP2023520409A (ja) | 2023-05-17 |
| JP2023520409A5 true JP2023520409A5 (enExample) | 2024-03-29 |
| JP7840865B2 JP7840865B2 (ja) | 2026-04-06 |
Family
ID=77929997
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559600A Active JP7840865B2 (ja) | 2020-03-31 | 2021-03-31 | キメラ抗原受容体ターゲティングｃｄ３３ |
| JP2026050913A Pending JP2026108769A (ja) | 2020-03-31 | 2026-03-25 | キメラ抗原受容体ターゲティングｃｄ３３ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026050913A Pending JP2026108769A (ja) | 2020-03-31 | 2026-03-25 | キメラ抗原受容体ターゲティングｃｄ３３ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12570758B2 (enExample) |
| EP (1) | EP4126959A4 (enExample) |
| JP (2) | JP7840865B2 (enExample) |
| CN (1) | CN115348973A (enExample) |
| CA (1) | CA3172691A1 (enExample) |
| WO (1) | WO2021202799A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022386336A1 (en) * | 2021-11-10 | 2024-05-16 | The Trustees Of The University Of Pennsylvania | Engineered chimeric antigen receptor (car) microglia-like cells for the treatment of neurodegenerative disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008045962A2 (en) * | 2006-10-10 | 2008-04-17 | Mayo Foundation For Medical Education And Research | Methods and materials related to anti-a (beta) antibodies |
| EP2814846B1 (en) | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| AR097648A1 (es) | 2013-09-13 | 2016-04-06 | Amgen Inc | Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide |
| ES2765710T3 (es) * | 2014-04-03 | 2020-06-10 | Cellectis | Receptores de antígeno quimérico específicos de CD33 para la inmunoterapia del cáncer |
| JP6831777B2 (ja) * | 2014-07-21 | 2021-02-17 | ノバルティス アーゲー | Ｃｄ３３キメラ抗原受容体を使用する癌の処置 |
| GB201514875D0 (en) | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| GB201518136D0 (en) | 2015-10-14 | 2015-11-25 | Glaxosmithkline Ip Dev Ltd | Novel chimeric antigen receptors |
| JP7189019B2 (ja) | 2016-02-05 | 2022-12-13 | シティ・オブ・ホープ | 中枢神経系の癌の治療のための操作されたｔ細胞の投与 |
| CN118652336A (zh) * | 2016-06-08 | 2024-09-17 | 普瑞赛格恩公司 | Cd33特异性嵌合抗原受体 |
| US20190233534A1 (en) | 2016-07-14 | 2019-08-01 | Fred Hutchinson Cancer Research Center | Multiple bi-specific binding domain constructs with different epitope binding to treat cancer |
| KR102709603B1 (ko) * | 2017-02-28 | 2024-09-27 | 보르 바이오파마 인크. | 계통 특이적 단백질의 억제를 위한 조성물 및 방법 |
| AU2018240556B2 (en) | 2017-03-24 | 2025-02-27 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-CD33 immunotherapy |
| GB201707779D0 (en) | 2017-05-15 | 2017-06-28 | Autolus Ltd | Cell |
| WO2018218207A1 (en) | 2017-05-26 | 2018-11-29 | Fred Hutchinson Cancer Research Center | Anti-cd33 antibodies and uses thereof |
| WO2019084234A1 (en) | 2017-10-26 | 2019-05-02 | St. Jude Childen's Research Hospital, Inc. | METHODS AND COMPOSITIONS FOR TREATING CD33 + CANCERS AND IMPROVING IN VIVO PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR T CELLS |
| US20210017277A1 (en) | 2018-03-14 | 2021-01-21 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Anti-cd33 chimeric antigen receptors and their uses |
| JOP20190116A1 (ar) | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
| WO2019246593A2 (en) | 2018-06-22 | 2019-12-26 | Fred Hutchinson Cancer Research Center | Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders |
| EP4126248A4 (en) * | 2020-03-31 | 2024-07-10 | Fred Hutchinson Cancer Center | HUMAN ANTI-CD33 ANTIBODIES AND THEIR USES |
| EP4126925A4 (en) | 2020-03-31 | 2024-07-24 | Fred Hutchinson Cancer Center | CHIMERIC ANTIGEN RECEPTORS TARGETED AGAINST CD33 |
-
2021
- 2021-03-31 JP JP2022559600A patent/JP7840865B2/ja active Active
- 2021-03-31 CN CN202180025359.2A patent/CN115348973A/zh active Pending
- 2021-03-31 WO PCT/US2021/025255 patent/WO2021202799A2/en not_active Ceased
- 2021-03-31 US US17/907,648 patent/US12570758B2/en active Active
- 2021-03-31 EP EP21780751.0A patent/EP4126959A4/en active Pending
- 2021-03-31 CA CA3172691A patent/CA3172691A1/en active Pending
-
2026
- 2026-02-05 US US19/531,427 patent/US20260167738A1/en active Pending
- 2026-03-25 JP JP2026050913A patent/JP2026108769A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520410A5 (enExample) | ||
| US12048718B2 (en) | Chimeric antigen receptor and CAR-T cells that bind BCMA | |
| JP2022184852A5 (enExample) | ||
| JP2022173235A (ja) | Ｂｃｍａ関連癌および自己免疫疾患の治療のための併用療法 | |
| DK2900694T3 (en) | BISPECIFIC IGG ANTIBODIES AS T-CELL ACTIVATORS | |
| JP2009502171A5 (enExample) | ||
| CN112105649B (zh) | 二聚体抗原受体(dar) | |
| TWI373475B (en) | Recombinant triplex scaffold-based polypeptides | |
| JP2020022456A5 (enExample) | ||
| JP2018523485A5 (enExample) | ||
| TW202216754A (zh) | 雙特異性抗體car細胞免疫療法 | |
| JP2013063981A5 (enExample) | ||
| JP2021518108A5 (enExample) | ||
| JP2014534242A5 (enExample) | ||
| KR20160142345A (ko) | 변형된 j-사슬 | |
| Kaweme et al. | Optimizing NK cell-based immunotherapy in myeloid leukemia: abrogating an immunosuppressive microenvironment | |
| JP2022527081A5 (enExample) | ||
| WO2020172641A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| CA3149867A1 (en) | Dimeric antigen receptors (dar) that bind bcma | |
| AU2018345400B2 (en) | Methods for selectively expanding cells expressing a TCR with a murine constant region | |
| Asano et al. | Multimerization of anti‐(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers | |
| CN111662382A (zh) | 特异结合cd3的抗体、抗原结合片段和单链抗体可变区片段及其应用 | |
| JP2022554187A5 (enExample) | ||
| JPWO2021020564A5 (enExample) | ||
| JP7840865B2 (ja) | キメラ抗原受容体ターゲティングｃｄ３３ |